Status:
COMPLETED
Safety and Efficacy of a Single Dose of a Polyphenol-enriched Brown Seaweed Powder in Human
Lead Sponsor:
innoVactiv Inc.
Conditions:
Glycemic Index
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
Brief Summary
The primary endpoint of this trial will be to evaluate the safety of a single administration in human of a dose of 500 mg of a polyphenol-rich algal powder when taken 30 minutes before a test meal. Th...
Eligibility Criteria
Inclusion
- Healthy volunteer
- BMI between 20 and 30
- Non-smoking
Exclusion
- Iodine allergy
- Diabetes
- Use of dietary supplements for duration of study
- History of major surgeries or surgeries of the stomach or digestive tract
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2010
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00936754
Start Date
July 1 2009
End Date
January 1 2010
Last Update
January 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut des Nutraceutiques et des Aliments Fonctionnels (INAF)
Québec, Quebec, Canada, G1V 0A6